Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors
Application
US20260078105A1
Kind: A1
Mar 19, 2026
Inventors
Archana Vijayakumar, Gary Phillips, Eisuke Murakami, G. Mani Subramanian
Abstract
Disclosed herein are inhibitors of aminocarboxymuconate semialdehyde decarboxylase (ACMSD), pharmaceutical compositions and methods for using these compounds to treat or prevent one or more ACMSD-related diseases such as, for example, muscle structure disorders, neuronal activation disorders, muscle fatigue disorders, muscle mass disorders, beta oxidation diseases, metabolic diseases, cancer, vascular diseases, ocular vascular diseases, muscular eye diseases, liver diseases, inflammatory diseases or renal diseases.
CPC Classifications
C07D 401/12
A61K 31/4418
A61K 31/4439
A61K 31/444
A61K 31/496
A61K 31/506
A61K 31/513
A61K 31/53
C07D 213/85
C07D 239/56
C07D 401/14
C07D 403/12
Filing Date
2024-10-11
Application No.
18913029